Evidence map›Paper›PMID 38679461›Full record

ArticleInternational journal of technology assessment in health care2024

A situational and stakeholder analysis of health technology assessment in Zimbabwe.

Blessing Dzingirai, Prudence Dambiko, Celia Matyanga, Pinky Manyau, Dexter Tagwireyi, Maarten J Postma, Nyashadzaishe Mafirakureva, Marinus van Hulst

Abstract read
In one paragraph

Article in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Blessing DzingiraiDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.ORCID https://orcid.org/0000-0001-8208-7821
Prudence DambikoDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Celia MatyangaDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Pinky ManyauDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Dexter TagwireyiDepartment of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Maarten J PostmaDepartment of Economics, Econometrics & Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
Nyashadzaishe MafirakurevaHealth Economics and Decision Science, School of Health and Related Research, University of Sheffield, UK.
Marinus van HulstDepartment of Economics, Econometrics & Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSystematic priority setting is necessary for achieving high-quality healthcare using limited resources in low- and middle-income countries. Health technology assessment (HTA) is a tool that can be used for systematic priority setting. The objective of this study was to conduct a stakeholder and situational analysis of HTA in Zimbabwe.

methodsWe identified and analyzed stakeholders using the International Decision Support Initiative checklist. The identified stakeholders were invited to an HTA workshop convened at the University of Zimbabwe. We used an existing HTA situational analysis questionnaire to ask for participants' views on the need, demand, and supply of HTA. A follow-up survey was done among representatives of stakeholder organizations that failed to attend the workshop. We reviewed two health policy documents relevant to the HTA. Qualitative data from the survey and document review were analyzed using thematic analysis.

resultsForty-eight organizations were identified as stakeholders for HTA in Zimbabwe. A total of 41 respondents from these stakeholder organizations participated in the survey. Respondents highlighted that the HTA was needed for transparent decision making. The demand for HTA-related evidence was high except for the health economic and ethics dimensions, perhaps reflecting a lack of awareness. Ministry of Health was listed as a major supplier of HTA data.

conclusionsThere is no formal HTA agency in the Zimbabwe healthcare system. Various institutions make decisions on prioritization, procurement, and coverage of health services. The activities undertaken by these organizations provide context for the institutionalization of HTA in Zimbabwe.

Indexed as

Stakeholder ParticipationTechnology Assessment, BiomedicalDecision MakingHealth PolicyHealth PrioritiesHumansZimbabwehealth technology assessmentlow and middle income countriespriority settingstakeholder participationUniversal Health CoverageZimbabwe

Identifiers

PMID38679461
PMCPMC11569906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.